Equity Capital And Reserves Cambio Fecha
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Astellas Pharma JPY 1.64T 60.93B 2023-09
AstraZeneca USD 37.2B 195M 2023-09
Bayer EUR 33.38B 3.57B 2023-09
BioCryst Pharmaceuticals USD -410986000 22.27M 2023-09
Bluebird Bio USD 222.54M 66.48M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Eisai JPY 861.67B 16.8B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Exelixis USD 2.35B 180.32M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
J&J USD 71.23B 3.92B 2023-09
Merck USD 41.25B 2.55B 2023-09
Moderna USD 13.85B 399M 2023-12
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Roche Holding CHF 26.52B 1.48B 2023-06
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Takeda JPY 7.07T 149.3B 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12



Mirati Therapeutics Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.